From day one, we work with you to create a roadmap to manufacturability. Our configurable technology platforms are designed for maximum flexibility to accommodate your specific requirements for integrated, semi-automated or fully automated production – whether for a single unit process or multiple applications. Our collaborative team of cell therapy scientists, manufacturing and operations specialists bring strategic insights and expert knowledge to create a pathway that accelerates your therapy to market.

Cell and gene therapeutic products demand consistent quality and reliable yield reproducibility. Our scientists and engineers work with you to design a solution that yields quality outputs in each unit operation. We integrate unit operations to fully automate production systems that reduce costs, variability and errors associated with manual processes.

We are fully invested in accelerating the availability of lifesaving cell and gene therapies to more people. Our user-centered approach to design engineering means our cell therapy solutions are more intuitive to operate, efficient to run and simpler to maintain. And that means lower costs. As your cooperative technical partner, we work swiftly and collaboratively with you to configure a manufacturing solution that fits your process and scales to your requirements. So you can get cost-effective therapies to more people, more efficiently.